Virtu Financial LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 74 filers reported holding FATE THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$147
-99.9%
14,594
+15.2%
0.02%
-26.9%
Q3 2022$284,000
-70.7%
12,673
+7.8%
0.03%
-62.3%
Q1 2021$970,000
+502.5%
11,759
-28.8%
0.07%
+666.7%
Q1 2018$161,000
+43.8%
16,521
-9.5%
0.01%
+50.0%
Q4 2017$112,000
+53.4%
18,251
-1.3%
0.01%
+50.0%
Q3 2017$73,00018,4930.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 716,392$11,126,00012.18%
Polaris Venture Management Co. V, L.L.C. 1,139,783$17,701,00010.06%
Grosvenor Holdings, L.L.C. 2,285,714$35,497,0006.41%
Redmile Group, LLC 11,216,809$174,197,0005.83%
Casdin Capital, LLC 2,550,000$39,601,500,0004.10%
DAFNA Capital Management LLC 470,000$7,299,0002.74%
Ghost Tree Capital, LLC 350,000$5,436,0001.38%
Artal Group S.A. 2,000,000$31,060,0001.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,952,897$30,328,0001.24%
Copernicus Capital Management, LLC 75,000$1,165,0001.08%
View complete list of FATE THERAPEUTICS INC shareholders